St. John's Wort
St. John's Wort can induce drug-metabolizing enzymes and transporters and may lower Itraconazole exposure or undermine therapy.
Recommendation: Avoid St. John's Wort with Itraconazole.
Prescription ·Strong evidence ·Reviewed May 2026
Itraconazole is a broad-spectrum triazole antifungal used to treat a range of systemic and superficial fungal infections, including aspergillosis, blastomycosis, histoplasmosis, onychomycosis (nail fungus), and oropharyngeal/esophageal candidiasis. It is fungistatic against most pathogens and is available as capsules, an oral solution, and a delayed-release/enhanced-bioavailability formulation. Its absorption and many of its drug interactions are clinically important: capsule absorption requires gastric acid, while the oral solution is best taken on an empty stomach.
The bottom line
Evidence rating strong. Most-documented uses: treatment of onychomycosis (fungal nail infection) of the toenails and fingernails, treatment of systemic mycoses including blastomycosis and histoplasmosis, treatment of invasive and non-invasive aspergillosis in patients intolerant of or refractory to amphotericin b. 4 sources indexed (2000–2018), with 7 interaction records on file.
Core mechanism
Itraconazole inhibits the fungal cytochrome P450 enzyme lanosterol 14-alpha-demethylase (encoded by ERG11/CYP51), which is required for the conversion of lanosterol to ergosterol. Blocking this step depletes ergosterol, an essential component of the fungal cell membrane, and causes accumulation of toxic methylated sterol precursors. The result is increased membrane permeability and disruption of membrane-bound enzyme function, inhibiting fungal growth. Itraconazole is also a potent inhibitor of human CYP3A4 and of P-glycoprotein, which underlies its extensive drug-interaction profile.4,1
Itraconazole is highly lipophilic. Capsule absorption is enhanced by food and requires an acidic gastric environment, so capsules should be taken with a full meal and ideally an acidic beverage (such as a cola); acid-suppressing drugs (proton pump inhibitors, H2 blockers, antacids) markedly reduce capsule absorption. In contrast, the oral solution and certain enhanced-bioavailability capsules (e.g., Tolsura) are best absorbed on an empty stomach. Formulations are not interchangeable on a milligram-per-milligram basis.
St. John's Wort can induce drug-metabolizing enzymes and transporters and may lower Itraconazole exposure or undermine therapy.
Recommendation: Avoid St. John's Wort with Itraconazole.
Concentrated green tea extract has been associated with liver injury, which can complicate use of hepatotoxic drugs such as Itraconazole.
Recommendation: Avoid high-dose green tea extract during therapy or use only with clinician review, especially if liver enzymes are abnormal or symptoms of hepatitis occur.
Berberine may inhibit CYP3A4 or P-glycoprotein and could increase itraconazole intolerance in susceptible patients.
Recommendation: Avoid high-dose berberine unless the prescriber has reviewed the full medication list.
Calcium supplements, particularly calcium carbonate, raise gastric pH and can substantially reduce the dissolution and absorption of itraconazole capsules, which require an acidic stomach environment to dissolve. This may lead to subtherapeutic antifungal concentrations and treatment failure.
Recommendation: Separate calcium supplements from itraconazole capsules by at least 2 hours. Take itraconazole capsules with food and an acidic beverage (such as a cola) when possible. The oral solution and SUBA formulation are less pH-dependent and may be preferred if frequent calcium use is required. Discuss persistent infections with the prescriber.
Oral iron salts are best absorbed in an acidic environment and are sometimes taken with antacids or co-administered with acid-reducing agents; more importantly, conditions and products that raise gastric pH impair itraconazole capsule absorption. Co-timing iron-containing multivitamin/antacid combinations with itraconazole can lower antifungal exposure.
Recommendation: Take itraconazole capsules with an acidic beverage and food, and separate from iron supplements (especially those formulated with calcium or buffering agents) by at least 2 hours. Monitor for signs of inadequate antifungal response.
St. John's Wort is a potent inducer of CYP3A4 and P-glycoprotein. Itraconazole is extensively metabolized by CYP3A4, so concomitant use markedly increases itraconazole clearance and can reduce plasma concentrations to subtherapeutic levels, risking antifungal treatment failure.
Recommendation: Avoid combining St. John's Wort with itraconazole. If an antidepressant or mood supplement was being used, discuss alternatives with the prescriber. Because enzyme induction persists for one to two weeks after stopping St. John's Wort, do not assume immediate normalization of itraconazole levels.
Milk thistle (silymarin) has shown weak and inconsistent effects on CYP3A4 and P-glycoprotein in laboratory studies. While clinically significant interaction with itraconazole is unlikely at typical doses, milk thistle is often used by people with liver concerns, and itraconazole carries a risk of hepatotoxicity, so liver status warrants attention.
Recommendation: Routine concurrent use is generally acceptable, but monitor for symptoms of liver stress (nausea, dark urine, jaundice, right-upper-quadrant pain) during itraconazole therapy and report them promptly. Do not rely on milk thistle to prevent drug-induced liver injury.
Numbered references. Citations throughout the page link here.
Both continuous and pulse itraconazole regimens achieved clinical and mycological cure in dermatophyte toenail onychomycosis, with pulse dosing reducing total drug exposure.
Itraconazole capsule bioavailability depends on an acidic gastric environment and food, while the cyclodextrin oral solution achieves higher and more reliable exposure when taken fasting.
Cases of congestive heart failure were associated with itraconazole, supporting a boxed warning and contraindication of itraconazole for onychomycosis in patients with ventricular dysfunction or CHF.
Itraconazole is a triazole antifungal that inhibits ergosterol synthesis; capsule absorption requires gastric acidity and is enhanced by food, and the drug is a potent CYP3A4 inhibitor with multiple contraindicated coadministrations.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.